Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clonidine 25microgram tablets
0407042F0AAAAAA
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 60,215 |
|
Clonidine 50micrograms/5ml oral solution sugar free
0407042F0AAAZAZ
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 3,940 |
|
Clonidine 50micrograms/5ml oral liquid
0407042F0AAAFAF
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 71 |
|
Clonidine 100micrograms/5ml oral liquid
0407042F0AAALAL
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 8 |
|
Clonidine 125micrograms/5ml oral liquid
0407042F0AAARAR
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 250micrograms/5ml oral solution
0407042F0AAAVAV
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 25micrograms/5ml oral liquid
0407042F0AAAGAG
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 3.75micrograms/5ml oral suspension
0407042F0AAAYAY
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 100micrograms/5ml oral solution sugar free
0407042F0AABBBB
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 10micrograms/5ml oral liquid
0407042F0AAAMAM
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 12.5micrograms/5ml oral liquid
0407042F0AAANAN
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 15micrograms/5ml oral liquid
0407042F0AAAKAK
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 250micrograms/5ml oral suspension
0407042F0AAAWAW
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 37.5micrograms/5ml oral liquid
0407042F0AAAQAQ
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 40micrograms/5ml oral suspension
0407042F0AABABA
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 45micrograms/5ml oral liquid
0407042F0AAAEAE
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 5micrograms/5ml oral liquid
0407042F0AAAJAJ
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 6.25micrograms/5ml oral liquid
0407042F0AAAPAP
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 62.5micrograms/5ml oral suspension
0407042F0AAAXAX
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 750micrograms/5ml oral liquid
0407042F0AAAIAI
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 75micrograms/5ml oral liquid
0407042F0AAAHAH
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 90micrograms/5ml oral liquid
0407042F0AAASAS
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.